Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Effect of Routine Invasive vs Conservative Strategy in Older Adults With Frailty and Non-ST-Segment Elevation Acute Myocardial Infarction: A Randomized Clinical Trial.

PMID: 36877502
Journal: JAMA Internal Medicine
Year: 2023
Reference: JAMA Intern Med. 2023 May 1;183(5):407-415. doi: 10.1001/jamainternmed.2023.0047.
Impact factor:
Publication type: Paper in international publication
Authors: Alfonso, Fernando; Ariza-Sole, Albert; Barrabes, Jose A; Bueno, Hector; Calvo, Elena; Carol, Antoni; Diez-Villanueva, Pablo; Dominguez-Perez, Laura; Elizaga, Jaime; Formiga, Francesc et al.
DOI: 10.1001/jamainternmed.2023.0047

Effectiveness and persistence with selexipag in pulmonary arterial hypertension in the real-life setting.

PMID: 36720652
Journal: European Journal of Internal Medicine
Year: 2023
Reference: Eur J Intern Med. 2023 May;111:140-142. doi: 10.1016/j.ejim.2023.01.023. Epub 2023 Jan 30.
Impact factor:
Publication type: Letter or abstract
Authors: Blanco, I; Cruz Utrilla, A; Del Pozo, R; Escribano-Subias, P; Lopez-Meseguer, M et al.
DOI: 10.1016/j.ejim.2023.01.023

Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

PMID: 37434782
Journal: Frontiers in Cellular and Infection Microbiology
Year: 2023
Reference: Front Cell Infect Microbiol. 2023 Jun 26;13:1187999. doi: 10.3389/fcimb.2023.1187999. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Antela, Antonio; Arbones, Laia; Barrufet, Pilar; Boix, Vicente; Callejo, Anna Marino; Casadella, Maria; Cervanntes, Sara; Chamorro, Anna; Curran, Adria; Del Mar Gutierrez, Maria et al.
DOI: 10.3389/fcimb.2023.1187999

Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma: A Nonrandomized Clinical Trial.

PMID: 36995731
Journal: JAMA Oncology
Year: 2023
Reference: JAMA Oncol. 2023 May 1;9(5):656-663. doi: 10.1001/jamaoncol.2023.0056.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez, Rosa; Blay, Jean-Yves; Casali, Paolo G; Cruz Jurado, Josefina; Dei Tos, Angelo P; Fabbroni, Chiara; Gronchi, Alessandro; Gutierrez, Antonio; Hindi, Nadia; Italiano, Antoine et al.
DOI: 10.1001/jamaoncol.2023.0056

Effectiveness and safety of ustekinumab in bio-naive Crohn's disease patients: a multicentre observational retrospective study.

PMID: 36777363
Journal: Therapeutic Advances in Gastroenterology
Year: 2023
Reference: Therap Adv Gastroenterol. 2023 Feb 9;16:17562848231153560. doi: 10.1177/17562848231153560. eCollection 2023.
Impact factor:
Publication type: Paper in international publication
Authors: Angel, Ponferrada Diaz; Beatriz, Lopez Cauce; Benito, Velayos Jimenez; Claudia, Herrera de Guise; Claudia, Herrera de Guise; Esteban, Fuentes-Valenzuela; Federico, Arguelles-Arias; Francisco, Mesonero Gismero; Lilyan, Kolle Casso; Luigi, Melcarne et al.
DOI: 10.1177/17562848231153560

Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.

PMID: 37684497
Journal: CNS DRUGS
Year: 2023
Reference: CNS Drugs. 2023 Sep 9. doi: 10.1007/s40263-023-01033-4.
Impact factor:
Publication type: Paper in international publication
Authors: Besson, Herve; Chinn, Chris; D'Souza, Wendyl; Daniels, Tony; Faught, Edward; Floricel, Florin; Friesen, David; Insuga, Victor Soto; Klein, Pavel; Laloyaux, Cedric et al.
DOI: 10.1007/s40263-023-01033-4

Effectiveness of an online multicomponent program (FATIGUEWALK) for chronic fatigue syndrome: A randomized controlled trial.

PMID: 38127508
Journal: HEALTH PSYCHOLOGY
Year: 2023
Reference: Health Psychol. 2023 Dec 21. doi: 10.1037/hea0001346.
Impact factor:
Publication type: Paper in international publication
Authors: Auer, William; Borras, Xavier; Feliu-Soler, Albert; Ferres, Sonia; Luciano, Juan V; Navarrete, Jaime; Neblett, Randy; Nieto, Ruben; Sanmartin-Sentanes, Ramon; Serrat, Mayte et al.
DOI: 10.1037/hea0001346

Effects of a telerehabilitation program and detraining on cardiorespiratory fitness in patients with post-COVID-19 sequelae: A randomized controlled trial.

PMID: 38009852
Journal: SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS
Year: 2023
Reference: Scand J Med Sci Sports. 2023 Nov 27. doi: 10.1111/sms.14543.
Impact factor:
Publication type: Paper in international publication
Authors: Del Carmen, Amin; Garnacho-Castano, Manuel V; Len, O; Miravitlles, Marc; Moreno, Eva; Pleguezuelos, Eulogio; Serra, Mateu; Villamarin, M et al.
DOI: 10.1111/sms.14543

Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis.

PMID: 36396142
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2023
Reference: Eur Respir J. 2023 Mar 2;61(3):2201426. doi: 10.1183/13993003.01426-2022. Print 2023 Mar.
Impact factor:
Publication type: Paper in international publication
Authors: Adell-Serrano, Berta; Aguilera, Luciano; Amaya-Villar, Rosario; Anon, Jose Manuel; Barbe, Ferran; Barbera, Carme; Barberan, Jose; Barbeta, Enric; Blandino, Aaron; Boado, Maria Victoria et al.
DOI: 10.1183/13993003.01426-2022

Effects of maternal modafinil treatment on fetal development and neonatal growth parameters - a multicenter case series of the European Network of Teratology Information Services (ENITS).

PMID: 38110225
Journal: ACTA PSYCHIATRICA SCANDINAVICA
Year: 2023
Reference: Acta Psychiatr Scand. 2023 Dec 18. doi: 10.1111/acps.13643.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilera, Cristina; Back, Magnus; Beghin, Delphine; Bera, Annie Pierre Jonville; Bermejo-Sanchez, Eva; Bosch, Montserrat; Brida, Margarita; Cassina, Matteo; Chieffo, Alaide; Chouchana, Laurent et al.
DOI: 10.1111/acps.13643

Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma.

PMID: 37496871
Journal: Open Respiratory Archives
Year: 2023
Reference: Open Respir Arch. 2023 Jan 3;5(2):100231. doi: 10.1016/j.opresp.2022.100231. eCollection 2023 Apr-Jun.
Impact factor:
Publication type: Review in international publication
Authors: Canete, Conxa; Domingo, Christian; Martinez Rivera, Carlos; Munoz, Xavier; Plaza, Vicente et al.
DOI: 10.1016/j.opresp.2022.100231

Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.

PMID: 37027155
Journal: JAMA Network Open
Year: 2023
Reference: JAMA Netw Open. 2023 Apr 3;6(4):e237243. doi: 10.1001/jamanetworkopen.2023.7243.
Impact factor:
Publication type: Paper in international publication
Authors: Abdilla-Bonias, Noelia; Alende-Sixto, Rosario; Alvarez-Suarez, Ana Maria; Alvarez-Troncoso, Jorge; Andrade-Pina, Ariadna Helena; Arevalo, Coral; Argibay, Ana Belen; Arnaez, Ruben; Arnalich, Francisco; Bara, Nuria et al.
DOI: 10.1001/jamanetworkopen.2023.7243

Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry.

PMID: 37964032
Journal: Gastric Cancer
Year: 2023
Reference: Gastric Cancer. 2023 Nov 15. doi: 10.1007/s10120-023-01443-9.
Impact factor:
Publication type: Paper in international publication
Authors: Abate, Emmanuele; Abdallah, Hussein; Adinolfi, Elvira; Agnesi, Stefano; Aguzzi, Daniele; Aisoni, Filippo; Albertini, Nicola; Allaix, Marco E; Altieri, Caterina; Amato, Antonio et al.
DOI: 10.1007/s10120-023-01443-9

Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.

PMID: 37016556
Journal: HIV MEDICINE
Year: 2023
Reference: HIV Med. 2023 Apr 4. doi: 10.1111/hiv.13489.
Impact factor:
Publication type: Paper in international publication
Authors: Casado, J L; Castano, M; de la Torre, J; Fanjul, F; Farinas, C; Galindo, M J; Gomez-Ayerbe, C; Hidalgo, C; Montero, M; Montes, M L et al.
DOI: 10.1111/hiv.13489

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.

PMID: 37962077
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2023
Reference: N Engl J Med. 2023 Nov 13. doi: 10.1056/NEJMoa2306185.
Impact factor:
Publication type: Paper in international publication
Authors: Addy, Carol; Akarca, Ulus S; Allende, Daniela S; Allende, Daniela S; Alvares-da-Silva, Mario Reis; Amaddeo, Giuliana; Andreone, Pietro; Argemi, Josepmaria; Argemi, Josepmaria; Arrese, Marco et al.
DOI: 10.1056/NEJMoa2306185

Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study.

PMID: 38102535
Journal: BMC Neurology
Year: 2023
Reference: BMC Neurol. 2023 Dec 15;23(1):441. doi: 10.1186/s12883-023-03477-z.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Palomo, B; Aran, B; Castano, J; Ettrup, Anders; Florea, Ioana; Jansson, Gary; Kuebler, B; Luo, Guogang; Pozo-Rosich, Patricia; Querol Giner, S et al.
DOI: 10.1186/s12883-023-03477-z

Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study.

PMID: 36535300
Journal: Lancet Respiratory Medicine
Year: 2023
Reference: Lancet Respir Med. 2023 Apr;11(4):354-366. doi: 10.1016/S2213-2600(22)00437-4. Epub 2022 Dec 16.
Impact factor:
Publication type: Paper in international publication
Authors: Bauer, Todd M; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Iadeluca, Laura; Jassem, Jacek; Kim, Dong-Wan; Liu, Geoffrey; Lopez, Froylan Lopez; Mazieres, Julien et al.
DOI: 10.1016/S2213-2600(22)00437-4

Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma.

PMID: 36680880
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2023
Reference: Eur J Cancer. 2023 Mar;181:188-197. doi: 10.1016/j.ejca.2022.12.013. Epub 2022 Dec 27.
Impact factor:
Publication type: Paper in international publication
Authors: Arance, Ana; Bai, Kun; Balko, Justin M; Blum, Steven M; Buchbinder, Elizabeth I; Carlino, Matteo S; Da Silva, Ines P; Gonzalez-Espinoza, Ivan R; Huertas, Roberto M; Jara-Casas, Diego et al.
DOI: 10.1016/j.ejca.2022.12.013

Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

PMID: 38106570
Journal: Kidney International Reports
Year: 2023
Reference: Kidney Int Rep. 2023 Sep 22;8(12):2754-2764. doi: 10.1016/j.ekir.2023.09.017. eCollection 2023 Dec.
Impact factor:
Publication type: Paper in international publication
Authors: Biondani, Andrea; Cavero, Teresa; Chaperon, Frederique; Daina, Erica; Eisenberger, Ute; Ettrup, Anders; Florea, Ioana; Gackler, Anja; Garcia-Carro, Clara; Jansson, Gary et al.
DOI: 10.1016/j.ekir.2023.09.017

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.

PMID: 37311468
Journal: LANCET
Year: 2023
Reference: Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874-7.
Impact factor:
Publication type: Paper in international publication
Authors: Cluzeau, Thomas; Degulys, Andrius; Della Porta, Matteo Giovanni; Dimicoli-Salazar, Sophie; Fenaux, Pierre; Garcia-Manero, Guillermo; Giuseppi, Ana Carolina; Hayati, Sheida; Jonasova, Anna; Keeperman, Karen L et al.
DOI: 10.1016/S0140-6736(23)00874-7

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.

PMID: 36716407
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 May 1;41(13):2436-2445. doi: 10.1200/JCO.22.01900. Epub 2023 Jan 30.
Impact factor:
Publication type: Paper in international publication
Authors: Coleman, Robert L; Colombo, Nicoletta; Dean, Andrew; Denys, Hannelore; Esteves, Brooke; Harter, Philipp; Konner, Jason A; Lorusso, Domenica; Marin, Margarita Romeo; Matulonis, Ursula A et al.
DOI: 10.1200/JCO.22.01900

Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.

PMID: 37597162
Journal: ALLERGY
Year: 2023
Reference: Allergy. 2023 Aug 19. doi: 10.1111/all.15854.
Impact factor:
Publication type: Paper in international publication
Authors: Baron, Jens; Brehler, Randolf; Ferrer, Marta; Gimenez-Arnau, Ana Maria; Groffik, Adriane; Grundmann, Sonja; Jakob, Thilo; Labrador-Horrillo, Moises; Maurer, Marcus; Metz, Martin et al.
DOI: 10.1111/all.15854

Efficacy and Safety of Oral Factor XIa Inhibitors in Stroke Prevention: A Systematic Review and Meta-Analysis.

PMID: 37685629
Journal: Journal of Clinical Medicine
Year: 2023
Reference: J Clin Med. 2023 Aug 26;12(17):5562. doi: 10.3390/jcm12175562.
Impact factor:
Publication type: Review in international publication
Authors: Alexandrov, Andrei; Caso, Valeria; Eleftheriou, Andreas; Karapanayiotides, Theodore; Katsanos, Aristeidis H; Lemmens, Robin; Mitsias, Panayiotis D; Molina, Carlos A; Molina, Carlos A; Palaiodimou, Lina et al.
DOI: 10.3390/jcm12175562

Efficacy and Safety of Pea Protein and Xyloglucan Versus Simethicone in Functional Abdominal Bloating and Distension.

PMID: 37923826
Journal: DIGESTIVE DISEASES AND SCIENCES
Year: 2023
Reference: Dig Dis Sci. 2023 Nov 3. doi: 10.1007/s10620-023-08155-1.
Impact factor:
Publication type: Paper in international publication
Authors: Belohlavek, Jan; Dimitrova, Emiliya; Elenski, Kiril; Etropolska, Zlatka; Jung, Christian; Petrisor, Diana Corina; Riera, Jordi; Santos, Javier et al.
DOI: 10.1007/s10620-023-08155-1

Publications